Objective To systematically review the literature and determine frequencies of adverse drug
events (ADE) associated with pediatric asthma medications. Methods Following PRISMA …

Background Respiratory medications are frequently prescribed for use in children. Several
studies have reported information on the safety of asthma medications in clinical studies in …

Background Information about safety issues from use of asthma medications in children is
limited. Spontaneous adverse drug reaction (ADR) reports can provide information about …

The introduction of long-acting beta agonists (LABAs) was considered a major advance in
bronchodilator therapy for adult, as well as pediatric, patients with asthma. However, the use …

Objectives Inhaled corticosteroids (ICS) are widely used in the treatment of asthma. We
studied the suspected adverse drug reactions (sADRs) reported during the use of ICS in the …

Objective. The global burden of pediatric asthma is high. Governments and health-care
systems are affected by the increasing costs of childhood asthma—in terms of direct health …

OBJECTIVE: To determine the risk, by age group, of serious asthma-related events with long-
acting β2-adrenergic receptor agonists marketed in the United States for asthma …

Background Asthma is the most common chronic disease of childhood and a major source
of childhood health burden worldwide. These burdens are particularly marked when …

Background Based on results of clinical trials, inhaled corticosteroids (ICS) are the most-
effective controller medications for preventing asthma-related exacerbations, yet few studies …

Specific concerns from 706 parents regarding their children's (M age= 8.0, SD= 3.9) use of
daily asthma medications were systematically identified and organized. 270 (38.2%) of 706 …